Biolinq Patents

Patent portfolio assigned to Biolinq (verified via public assignee records). San Diego biosensor / needle-free CGM company (Biolinq Shine). Competitors are major CGM makers (sourced). Amalgam Rx named as digital-platform partner. Patents confirmed (multiple US patents assigned to Biolinq Inc, e.g. US10092207B1, US12109032); exact count not displayed.